Improvement of production of standard isohemagglutinizing serum ABO kits from the point of import substitution and reduction of financial costs

  • Authors: Тураева Р.Р.1, Тураев Р.Г.2, Хакимова Р.И.2, Зарипова Р.М.2, Мингазова Э.Н.3,4,5, Жибурт Е.Б.6
  • Affiliations:
    1. Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, Kazan, Russia
    2. Republican Blood Center of the Ministry of Health of the Republic of Tatarstan, Kazan, Russia
    3. N. A. Semashko National Research Institute of Public Health, Moscow, Russia
    4. Russian Medical Academy of Continuous Professional Education, Moscow, Russia
    5. Kazan State Medical University, Kazan, Russia
    6. Pirogov National Medical and Surgical Center, Ministry of Health of Russia, Moscow, Russia
  • Issue: No 3 (2025)
  • Pages: 227-230
  • Section: Articles
  • URL: https://remedium-journal.ru/journal/article/view/1809
  • DOI: https://doi.org/10.32687/1561-5936-2025-29-3-227-230
  • Cite item

Abstract


The aim of this study was to prepare proposals to improve the production of standard ABO isohemagglutinin serum kits based on an assessment of the phenotypic, temporal, and gender characteristics of the prevalence of high-titer regular antibodies of the ABO system. Materials and methods. In 2021—2023, the Republican Blood Center of the Ministry of Health of the Republic of Tatarstan conducted a study of the titer of natural group antibodies in blood samples of all donors, except for group AB, in order to detect high (1:256 and higher) titers necessary for the production of standard ABO isohemagglutinin serum. A total of 38,795 donors were examined, high-titer regular antibodies of the ABO system were detected in 58 (15.0 ‰O). The phenotypic, temporal, and gender characteristics of the occurrence of high-titer regular antibodies of the ABO system were assessed. Results. The proportion of women among donors was 29.8%. Over the entire observation period, high-titer regular antibodies of the ABO system were found in women by 19.3 ‰O more often than in men (p<0.001). The frequency of occurrence of high-titer regular antibodies of the ABO system has no gender differences in the O and A phenotypes and is significantly higher in female donors of the B phenotype by 51.0 ‰O (p<0.001). Anti-B are less common than anti-A by 11.8 ‰O (p<0.03). Conclusion. The revealed increased frequency of anti-A in female donors of the Republic of Tatarstan allows us to recommend examining no more than 50% of female donors for high-titer regular antibodies and completely abandoning the search for these antibodies in men of group B. Based on the experience of 2021—2023 such a reduction would amount to 8662 out of 38795 studies or a reduction in material and labor costs by 22.3%.

About the authors

Роза Рамильевна Тураева

Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, Kazan, Russia

Email: turaeva_roza@bk.ru

Рамиль Габдельхакович Тураев

Republican Blood Center of the Ministry of Health of the Republic of Tatarstan, Kazan, Russia

Email: ramil.turaev@tatar.ru

Рамзия Ильгизовна Хакимова

Email: dls.rck@tatar.ru

Регина Маратовна Зарипова

Republican Blood Center of the Ministry of Health of the Republic of Tatarstan, Kazan, Russia

Email: dls.rck@tatar.ru

Эльмира Нурисламовна Мингазова

N. A. Semashko National Research Institute of Public Health, Moscow, Russia; Russian Medical Academy of Continuous Professional Education, Moscow, Russia; Kazan State Medical University, Kazan, Russia

Email: elmira_mingazova@mail.ru

Евгений Борисович Жибурт

Pirogov National Medical and Surgical Center, Ministry of Health of Russia, Moscow, Russia

Email: 006

References

  1. Zhiburt E. B., Chemodanov I. G., Averyanov E. G., Kozhemyako O. V. Sustainability of blood services. Bulletin of the National Research Institute of Public Health named after N. A. Semashko. 2017;(7):17—24 (In Russ.).
  2. Shevchenko Yu. L., Karpov O. E., Zhiburt E. B. Blood transfusion: history and modernity (on the 100th anniversary of blood transfusion in Russia). Bulletin of the Pirogov National Medical and Surgical Center. 2019;14(4):4—11 (In Russ.). doi: 10.25881/BPNMSC.2020.29.78.001
  3. Zhiburt E. B., Shestakov E. A., Kuznetsov S. I. Hemolytic transfusion reactions. Bulletin of the Pirogov National Medical and Surgical Center. 2019;14(4):105—111 (In Russ.). doi: 10.25881/BPNMSC.2020.17.22.020
  4. Zolotarev P. N., Cherkasov S. N. The market of medical laboratory services in the Russian Federation. Bulletin of the National Research Institute of Public Health named after N. A. Semashko. 2018;(4):14—18 (In Russ.). doi: 10.25742/NRIPH.2018.04.011
  5. Zhiburt E. B. Transfusiological dictionary. Moscow: RAEN; 2012 (In Russ.).

Statistics

Views

Abstract - 0

PDF (Russian) - 0

Cited-By


PlumX

Dimensions


Copyright (c) 2025 АО "Шико"

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: redactor@remedium-journal.ru

Phone: +7(495) 917-48-86



Principal Contact

Sherstneva Elena Vladimirovna
EXECUTIVE SECRETARY
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Email: redactor@remedium-journal.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies